+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

QSYMIA (Phentermine-Topiramate), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAXENDA (Liraglutide), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Digital Health For Obesity Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Digital Health For Obesity Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Anti-obesity Medication Market - Product Thumbnail Image

Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Non-invasive Fat Reduction Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Non-invasive Fat Reduction Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Anti-obesity Drugs Market - Product Thumbnail Image

Anti-obesity Drugs Market

  • Report
  • November 2023
  • 67 Pages
  • Global
From
South Korea Body Fat Reduction Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Thumbnail Image

South Korea Body Fat Reduction Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • May 2026
  • 200 Pages
  • South Korea
From
Obesity Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Obesity Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Anti-Obesity Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Anti-Obesity Drugs Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Asia Pacific Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Asia Pacific
From
Latin America Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Europe Anti-Obesity Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe Anti-Obesity Drugs Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Europe
From
Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Non-Invasive Fat Reduction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 113 Pages
  • Global
From
HET Obesity/POMC Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

HET Obesity/POMC Deficiency Obesity - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hypothalamic Obesity - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hypothalamic Obesity - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hypothalamic Obesity - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Anti-obesity Drugs Market 2025-2029 - Product Thumbnail Image

Anti-obesity Drugs Market 2025-2029

  • Report
  • March 2025
  • 228 Pages
  • Global
From
Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2024
  • 93 Pages
  • Global
From
Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 - Product Thumbnail Image

Obesity Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031

  • Drug Pipelines
  • March 2023
  • 136 Pages
  • Global
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more